Loading stock data…
Loading stock data…
US$0.55
Get one email when RVPH crosses your level. Checked every 15 minutes during market hours.
▼ -0.03 (-5.70%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.02
Bearish momentumMACD below its signal line (-0.02).
50-day average
0.58
Price belowShort-term trend reference.
200-day average
5.12
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company committed to the discovery and development of therapeutic drugs for the treatment of mental health disorders and other central nervous system diseases. The company is primarily focused on next-generation therapies targeting schizophrenia, bipolar disorder, and major depressive disorder, aiming to address unmet medical needs in these areas. Reviva’s lead product candidate is designed to support patients suffering …
www.revivapharma.com2 strong buy · 7 buy · 2 hold · 0 sell · 0 strong sell (11 analysts, 2026-05-01)
2 strong buy · 8 buy · 2 hold · 0 sell · 0 strong sell (12 analysts, 2026-04-01)
2 strong buy · 9 buy · 1 hold · 0 sell · 0 strong sell (12 analysts, 2026-03-01)
2 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (13 analysts, 2026-02-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-13 | -0.29 | -0.46 | ✗ Miss |
| 2026-03-30 | -1.07 | -5.19 | ✗ Miss |
| 2026-03-05 | 0.67 | 0.57 | ✗ Miss |
| 2025-12-04 | 0.92 | 0.94 | ✓ Beat |
| 2025-11-13 | -1.94 | -1.2 | ✓ Beat |
| 2025-08-14 | -2.2 | -2.4 | ✗ Miss |
| 2025-05-15 | -3.65 | -2.6 | ✓ Beat |
| 2025-03-31 | -4.4 | -3 | ✓ Beat |
Companies in the same industry, via Finnhub